Cargando…
Sphingosine‐1‐phosphate (S1P) receptors: Promising drug targets for treating bone‐related diseases
Sphingosine‐1‐phosphate (S1P) is a natural bioactive lipid molecule and a common first or second messenger in the cardiovascular and immune systems. By binding with its receptors, S1P can serve as mediator of signalling during cell migration, differentiation, proliferation and apoptosis. Although th...
Autores principales: | Zhang, Lincheng, Dong, Yutong, Wang, Yiran, Hu, Wenhui, Dong, Shiwu, Chen, Yueqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176849/ https://www.ncbi.nlm.nih.gov/pubmed/32155312 http://dx.doi.org/10.1111/jcmm.15155 |
Ejemplares similares
-
Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer
por: Xu, Guangmeng, et al.
Publicado: (2021) -
Sphingosine 1-Phosphate Receptor Modulators and Drug Discovery
por: Park, Soo-Jin, et al.
Publicado: (2017) -
Dendritic cells-derived interferon-λ1 ameliorated inflammatory bone destruction through inhibiting osteoclastogenesis
por: Chen, Yueqi, et al.
Publicado: (2020) -
The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis
por: Masuda-Kuroki, Kana, et al.
Publicado: (2023) -
A selected small molecule prevents inflammatory osteolysis through restraining osteoclastogenesis by modulating PTEN activity
por: Chen, Yueqi, et al.
Publicado: (2020)